Shin Enosawa
Clinical Research Center
National Center for Child Health and Development
Tokyo
Japan
Name/email consistency: high
- An improvement in the attaching capability of cryopreserved human hepatocytes by a proteinaceous high molecule, sericin, in the serum-free solution. Miyamoto, Y., Teramoto, N., Hayashi, S., Enosawa, S. Cell. Transplant (2010)
- The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model. Enosawa, S., Miyashita, T., Saito, T., Omasa, T., Matsumura, T. Cell. Transplant (2006)
- Transplantation of nonvascularized kidney tissue fragments into the rat liver with the aim of preserving renal function. Enosawa, S., Takahashi, N., Amemiya, H., Motomiya, Y. Cell. Transplant (2004)
- Establishment of public human tissue resource bank for research purposes with surgically removed tonsil tissue: potential scientific value and ethical problem. Enosawa, S., Suzuki, S., Amemiya, H., Tsuchihashi, N., Kawashiro, N., Utsugi, S., Matsumura, T. Transplant. Proc. (2002)
- In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure. Enosawa, S., Miyashita, T., Fujita, Y., Suzuki, S., Amemiya, H., Omasa, T., Hiramatsu, S., Suga, K., Matsumura, T. Cell. Transplant (2001)
- Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver. Enosawa, S., Miyashita, T., Suzuki, S., Li, X.K., Tsunoda, M., Amemiya, H., Yamanaka, M., Hiramatsu, S., Tanimura, N., Omasa, T., Suga, K., Matsumura, T. Cell. Transplant (2000)